Oncology and Cytogenetic Products' Seed Round

Oncology and Cytogenetic Products raised a round of funding on June 16, 2017. Investors include RebelBio.

Oncology and Cytogenetic Products, dba OaCP, develops, produces, and sells chemical patented reagents that reduce time for genetic diagnosis in oncology.…

Articles about Oncology and Cytogenetic Products' Seed Round: